Although limited literature has documented the relationship between m6A and TA-MSCs, our group confirmed that TA-MSCs express high levels of macrophage migration inhibitory factor (MIF), which enhances FTO expression in pancreatic cancer cells and promotes proliferation, migration and invasion (unpublished results). Here, MIF is linked to pancreatic neoplasm.